AAAAAA

   
Results: 1-21 |
Results: 21
FACTORS THAT INFLUENCE THE ANTIEMETIC ACTIVITY OF METOCLOPRAMIDE TO CISPLATIN-BASED CHEMOTHERAPY
Authors: TSAVARIS N MYLONAKIS N BACOYIANNIS C KOSMAS C KALERGIS G IAKOVIDIS V TZANINIS D KOSMIDIS P
Citation: N. Tsavaris et al., FACTORS THAT INFLUENCE THE ANTIEMETIC ACTIVITY OF METOCLOPRAMIDE TO CISPLATIN-BASED CHEMOTHERAPY, Oncology Reports, 5(5), 1998, pp. 1147-1155
AMINOGLUTETHAMIDE EFFECTIVENESS IN WOMEN WITH BREAST-CANCER OF AGE YOUNGER THAN 50
Authors: BACOYIANNIS C MALAMOS NA RIGATOS S STATHOPOULOS GP SAMELIS GF PAPAKOSTAS P
Citation: C. Bacoyiannis et al., AMINOGLUTETHAMIDE EFFECTIVENESS IN WOMEN WITH BREAST-CANCER OF AGE YOUNGER THAN 50, Annals of oncology, 9, 1998, pp. 83-83
PROGNOSTIC FACTORS INFLUENCING COMPLETE RESPONSE TO TREATMENT AND SURVIVAL OF PATIENTS WITH NASOPHARYNGEAL CANCER
Authors: KALOGERAFOUNTZILA A KOSMIDIS P BACOYIANNIS C NICOLAOU A SAMANTAS E BRIASSOULIS E PAVLIDIS N SKARLOS D DANILIDIS J FOUNTZILAS G
Citation: A. Kalogerafountzila et al., PROGNOSTIC FACTORS INFLUENCING COMPLETE RESPONSE TO TREATMENT AND SURVIVAL OF PATIENTS WITH NASOPHARYNGEAL CANCER, Anticancer research, 18(1B), 1998, pp. 587-593
A RANDOMIZED COMPARATIVE-STUDY OF ANTIEMETIC PROPHYLAXIS WITH ONDANSENTRON IN A SINGLE 32-MG LOADING DOSE VERSUS 8 MG EVERY 6 H IN PATIENTSUNDERGOING CISPLATIN-BASED CHEMOTHERAPY
Authors: TSAVARIS N FOUNTZILAS G MYLONAKIS N ATHANASSIADIS A KOSMAS C KARAKOUSIS C BACOYIANNIS C KOSMIDIS P
Citation: N. Tsavaris et al., A RANDOMIZED COMPARATIVE-STUDY OF ANTIEMETIC PROPHYLAXIS WITH ONDANSENTRON IN A SINGLE 32-MG LOADING DOSE VERSUS 8 MG EVERY 6 H IN PATIENTSUNDERGOING CISPLATIN-BASED CHEMOTHERAPY, Oncology, 55(6), 1998, pp. 513-516
PHASE-II STUDY OF INTERFERON-GAMMA (RIFN-G) AND VINBLASTINE (VBL) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA (RCC)
Authors: BACOYIANNIS C DIMOPOULOS MA NICOLAIDES C ARAVANTINOS G XIROS N SKARLOS D PAVLIDIS N KOSMIDIS P
Citation: C. Bacoyiannis et al., PHASE-II STUDY OF INTERFERON-GAMMA (RIFN-G) AND VINBLASTINE (VBL) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA (RCC), European journal of cancer, 33, 1997, pp. 177-177
PHASE-II STUDY OF CARBOPLATIN BASED CHEMOTHERAPY IN COMBINATION WITH MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED ENDOMETRIAL CANCER
Authors: BAFALOUKOS D ARAVANTINOS G SKARLOS D KATSIFIS G BACOYIANNIS C KOSMIDIS P
Citation: D. Bafaloukos et al., PHASE-II STUDY OF CARBOPLATIN BASED CHEMOTHERAPY IN COMBINATION WITH MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED ENDOMETRIAL CANCER, European journal of cancer, 33, 1997, pp. 953-953
CONTRIBUTION OF CHEMOTHERAPY (CMT) TO THE SURVIVAL(S) OF PATIENTS(P) WITH ADVANCED GASTRIC-CANCER (AGC) - A RETROSPECTIVE COMPARATIVE-STUDYOF PATIENTS WHO RECEIVED AND THOSE WHO REFUSED TREATMENT (TX)
Authors: TSAVARIS N KOSMIDIS P KOSMAS C KATSIKAS M BACOYIANNIS C MYLONAKIS N PAPALAMBROS E KOUFOS C BASTOUNIS E SECHAS M
Citation: N. Tsavaris et al., CONTRIBUTION OF CHEMOTHERAPY (CMT) TO THE SURVIVAL(S) OF PATIENTS(P) WITH ADVANCED GASTRIC-CANCER (AGC) - A RETROSPECTIVE COMPARATIVE-STUDYOF PATIENTS WHO RECEIVED AND THOSE WHO REFUSED TREATMENT (TX), European journal of cancer, 33, 1997, pp. 1276-1276
PACLITAXEL BY 3-HOUR INFUSION AND CARBOPLATIN IN ADVANCED-CARCINOMA OF NASOPHARYNX AND OTHER SITES OF THE HEAD AND NECK - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
Authors: FOUNTZILAS G SKARLOS D ATHANASSIADES A KALOGERAFOUNTZILA A SAMANTAS E BACOYIANNIS C NICOLAOU A DOMBROS N BRIASOULIS E DINOPOULOU M STATHOPOULOS G PAVLIDIS N KOSMIDIS P DANIILIDIS J
Citation: G. Fountzilas et al., PACLITAXEL BY 3-HOUR INFUSION AND CARBOPLATIN IN ADVANCED-CARCINOMA OF NASOPHARYNX AND OTHER SITES OF THE HEAD AND NECK - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP, Annals of oncology, 8(5), 1997, pp. 451-455
5-FLUOROURACIL, INTERFERON-ALPHA-2B AND CISPLATIN (FAP) FOR ADVANCED UROTHELIAL CANCER - A PHASE-II STUDY
Authors: KOSMIDIS PA BACOYIANNIS C FOUNTZILAS G ARAVANTINOS G TSAVARIS N MILATHIANAKIS C SKARLOS D
Citation: Pa. Kosmidis et al., 5-FLUOROURACIL, INTERFERON-ALPHA-2B AND CISPLATIN (FAP) FOR ADVANCED UROTHELIAL CANCER - A PHASE-II STUDY, Annals of oncology, 8(4), 1997, pp. 373-378
LONG-TERM SURVIVAL-DATA AND PROGNOSTIC FACTORS OF A COMPLETE RESPONSETO CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK-CANCER TREATED WITH PLATINUM-BASED INDUCTION CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: FOUNTZILAS G KOSMIDIS P AVRAMIDIS V NIKOLAOU A KALOGERAFOUNTZILA A MAKRANTONAKIS P BACOYIANNIS C SAMANTAS E SKARLOS D DANIILIDIS J
Citation: G. Fountzilas et al., LONG-TERM SURVIVAL-DATA AND PROGNOSTIC FACTORS OF A COMPLETE RESPONSETO CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK-CANCER TREATED WITH PLATINUM-BASED INDUCTION CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Medical and pediatric oncology, 28(6), 1997, pp. 401-410
PACLITAXEL IN COMBINATION WITH CARBOPLATIN OR GEMCITABINE FOR THE TREATMENT OF ADVANCED HEAD AND NECK-CANCER
Authors: FOUNTZILAS G ATHANASSIADES A KALOGERAFOUNTZILA A SAMANTAS E BACOYIANNIS C BRIASSOULIS E PAVLIDIS N KOSMIDIS P SKARLOS D
Citation: G. Fountzilas et al., PACLITAXEL IN COMBINATION WITH CARBOPLATIN OR GEMCITABINE FOR THE TREATMENT OF ADVANCED HEAD AND NECK-CANCER, Seminars in oncology, 24(6), 1997, pp. 28-32
BIOCHEMICAL MODULATION OF FLUOROURACIL - COMPARISON OF METHOTREXATE, FOLINIC ACID, AND FLUOROURACIL VERSUS FOLINIC ACID AND FLUOROURACIL INADVANCED COLORECTAL-CANCER - A RANDOMIZED TRIAL
Authors: POLYZOS A TSAVARIS N GIANNOPOULOS A BACOYIANNIS C PAPADIMAS V KALAHANIS N KARATZAS G KOSMAS C SAKELAROPOULOS N ARCHIMANDRITIS A PAPACHRISTODOULOU A KOSMIDIS P
Citation: A. Polyzos et al., BIOCHEMICAL MODULATION OF FLUOROURACIL - COMPARISON OF METHOTREXATE, FOLINIC ACID, AND FLUOROURACIL VERSUS FOLINIC ACID AND FLUOROURACIL INADVANCED COLORECTAL-CANCER - A RANDOMIZED TRIAL, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 292-297
USE OF NAPROXEN IN AMELIORATING INDUCED PARANEOPLASTIC FEVER
Authors: TSAVARIS N MYLONAKIS N BACOYIANNIS C KARVOUNIS N KORDOSSIS T DALIANI D KARABELIS A KOSMIDIS P
Citation: N. Tsavaris et al., USE OF NAPROXEN IN AMELIORATING INDUCED PARANEOPLASTIC FEVER, Clinical drug investigation, 10(1), 1995, pp. 8-11
5-FLUOROURACIL, FOLINIC ACID AND CISPLATIN IN ADVANCED COLORECTAL-CANCER - A PILOT-STUDY
Authors: TSAVARIS N TENTAS K BACOYIANNIS C KATSIKAS M SAKELAROPOULOS N KOSMAS C DALIANI D KOSMIDIS P
Citation: N. Tsavaris et al., 5-FLUOROURACIL, FOLINIC ACID AND CISPLATIN IN ADVANCED COLORECTAL-CANCER - A PILOT-STUDY, Anti-cancer drugs, 6(4), 1995, pp. 599-603
COMBINED EPIRUBICIN, EPIRUBICIN, 5-FLUOROURACIL AND FOLINIC ACID WITHALLOPURINOL PROTECTION FOR 2ND-LINE TREATMENT OF ADVANCED GASTRIC-CANCER - A PILOT-STUDY
Authors: TSAVARIS N MYLONAKIS N BACOYIANNIS C PAPASTRATIS G KATSIKAS M PAPADIMITRAKOPOULOU V MACHERAS A STAMELOU A KOSMIDIS P
Citation: N. Tsavaris et al., COMBINED EPIRUBICIN, EPIRUBICIN, 5-FLUOROURACIL AND FOLINIC ACID WITHALLOPURINOL PROTECTION FOR 2ND-LINE TREATMENT OF ADVANCED GASTRIC-CANCER - A PILOT-STUDY, Onkologie, 18(4), 1995, pp. 346-350
EFFICACY OF ONDANSETRON TREATMENT WITH DIFFERENT TIMING SCHEDULES - ARANDOMIZED DOUBLE-BLIND-STUDY
Authors: TSAVARIS N MYLONAKIS N BACOYIANNIS C KARVOUNIS N CHARALAMBIDIS G PAGOU M LIONI A DALIANI D KOSMIDIS P
Citation: N. Tsavaris et al., EFFICACY OF ONDANSETRON TREATMENT WITH DIFFERENT TIMING SCHEDULES - ARANDOMIZED DOUBLE-BLIND-STUDY, Oncology, 52(4), 1995, pp. 315-318
COMPARISON OF ONDANSENTRON VERSUS ONDANSENTRON PLUS METHYLPREDNISOLONE AS ANTIEMETIC PROPHYLAXIS DURING CISPLATIN-CONTAINING CHEMOTHERAPY
Authors: TSAVARIS N MYLONAKIS N BACOYIANNIS C KATSIKAS M LIONI A KOSMIDIS P
Citation: N. Tsavaris et al., COMPARISON OF ONDANSENTRON VERSUS ONDANSENTRON PLUS METHYLPREDNISOLONE AS ANTIEMETIC PROPHYLAXIS DURING CISPLATIN-CONTAINING CHEMOTHERAPY, Journal of pain and symptom management, 9(4), 1994, pp. 254-258
AN ALTERNATIVE SCHEDULE BASED ON IFOSFAMIDE (IFM) IN COMBINATION WITHDOXORUBICIN (ADM), VINCRISTIN (VCR) AND ACTINOMYCIN-D (ACTD) IN ADVANCED SOFT-TISSUE SARCOMAS (STS) OF ADULTS - A PILOT-STUDY
Authors: TSAVARIS N BACOYIANNIS C MYLONAKIS N KARVOUNIS N ZINELIS A TSOUTSOS E KOSMIDIS P
Citation: N. Tsavaris et al., AN ALTERNATIVE SCHEDULE BASED ON IFOSFAMIDE (IFM) IN COMBINATION WITHDOXORUBICIN (ADM), VINCRISTIN (VCR) AND ACTINOMYCIN-D (ACTD) IN ADVANCED SOFT-TISSUE SARCOMAS (STS) OF ADULTS - A PILOT-STUDY, Journal of experimental & clinical cancer research, 13(4), 1994, pp. 405-408
COMPARISON OF ONDANSENTRON (GR 3X032F) VERSUS ONDANSENTRON PLUS ALPRAZOLAM AS ANTIEMETIC PROPHYLAXIS DURING CISPLATIN-CONTAINING CHEMOTHERAPY
Authors: TSAVARIS N CHARALAMBIDIS G PAGOU M KARABELIS A MYLONAKIS N BACOYIANNIS C KOSMIDIS P
Citation: N. Tsavaris et al., COMPARISON OF ONDANSENTRON (GR 3X032F) VERSUS ONDANSENTRON PLUS ALPRAZOLAM AS ANTIEMETIC PROPHYLAXIS DURING CISPLATIN-CONTAINING CHEMOTHERAPY, American journal of clinical oncology, 17(6), 1994, pp. 516-521
COMBINATION CHEMOTHERAPY WITH CISPLATIN-VINBLASTINE IN MALIGNANT MESOTHELIOMA
Authors: TSAVARIS N MYLONAKIS N KARVOUNIS N BACOYIANNIS C BRIASOULIS E SKARLOS D PAVLIDIS N STAMATELOS G KOSMIDIS P
Citation: N. Tsavaris et al., COMBINATION CHEMOTHERAPY WITH CISPLATIN-VINBLASTINE IN MALIGNANT MESOTHELIOMA, Lung cancer, 11(3-4), 1994, pp. 299-303
TREATMENT OF RENAL-CELL CARCINOMA WITH ESCALATING DOSES OF ALPHA-INTERFERON
Authors: TSAVARIS N MYLONAKIS N BACOYIANNIS C TSOUTSOS H KARABELIS A KOSMIDIS P
Citation: N. Tsavaris et al., TREATMENT OF RENAL-CELL CARCINOMA WITH ESCALATING DOSES OF ALPHA-INTERFERON, Chemotherapy, 39(5), 1993, pp. 361-366
Risultati: 1-21 |